Search

Your search keyword '"Groen, H J"' showing total 390 results
Start Over Author "Groen, H J"
390 results on '"Groen, H J"'

8. Does radiomics have added value in predicting the development of brain metastases in patients with radically treated stage III non-small cell lung cancer (NSCLC)?

Author

Hendriks, L., Keek, S. A., Chatterjee, A., Belderbos, J., Bootsma, G., van den Borne, B., Dingemans, A-M. C., Gietema, H., Groen, H. J. M., Herder, G., Pitz, C., Praag, J., De Ruysscher, D., Schoenmaekers, J., Smit, H. J. M., Stigt, J., Westenend, M., Zeng, H., Woodruff, H., Lambin, P., Guided Treatment in Optimal Selected Cancer Patients (GUTS), and Damage and Repair in Cancer Development and Cancer Treatment (DARE)

Published
2022

10. 89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

Author

Epi Kanker Team C, Cancer, JC onderzoeksprogramma Kanker, Kok, I C, Hooiveld, J S, van de Donk, P P, Giesen, D, van der Veen, E L, Lub-de Hooge, M N, Brouwers, A H, Hiltermann, T J N, van der Wekken, A J, Hijmering-Kappelle, L B M, Timens, W, Elias, S G, Hospers, G A P, Groen, H J M, Uyterlinde, W, van der Hiel, B, Haanen, J B, de Groot, D J A, Jalving, M, de Vries, E G E, Epi Kanker Team C, Cancer, JC onderzoeksprogramma Kanker, Kok, I C, Hooiveld, J S, van de Donk, P P, Giesen, D, van der Veen, E L, Lub-de Hooge, M N, Brouwers, A H, Hiltermann, T J N, van der Wekken, A J, Hijmering-Kappelle, L B M, Timens, W, Elias, S G, Hospers, G A P, Groen, H J M, Uyterlinde, W, van der Hiel, B, Haanen, J B, de Groot, D J A, Jalving, M, and de Vries, E G E

Published
2022

11. A highly sensitive homologous human relaxin ELISA

Author

Armbruster, Franz P., Maier, Ina, Grön, H-J., Bailer, Susanne M., Dschietzig, Thomas, Stangl, Karl, Echner, Hartmut, Lippert, Theodor H., Seeger, H., Voelter, Wolfgang, Tregear, Geoffrey W., editor, Ivell, Richard, editor, Bathgate, Ross A., editor, and Wade, John D., editor

Published
2001
Full Text
View/download PDF

15. Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

Author

Barlesi, F., Scherpereel, A., Gorbunova, V., Gervais, R., Vikström, A., Chouaid, C., Chella, A., Kim, J. H., Ahn, M. J., Reck, M., Pazzola, A., Kim, H. T., Aerts, J. G, Morando, C., Loundou, A., Groen, H. J. M., and Rittmeyer, A.

Published
2014
Full Text
View/download PDF

18. Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients : Results from the NVALT-11/DLCRG-02 phase III study

Author

Witlox, W J A, Ramaekers, B L T, Joore, M A, Dingemans, A-M C, Praag, J, Belderbos, J, Tissing-Tan, C, Herder, G, Haitjema, T, Ubbels, J F, Lagerwaard, J, El Sharouni, S Y, Stigt, J A, Smit, E F, van Tinteren, H, van der Noort, V, Groen, H J M, De Ruysscher, D K M, Witlox, W J A, Ramaekers, B L T, Joore, M A, Dingemans, A-M C, Praag, J, Belderbos, J, Tissing-Tan, C, Herder, G, Haitjema, T, Ubbels, J F, Lagerwaard, J, El Sharouni, S Y, Stigt, J A, Smit, E F, van Tinteren, H, van der Noort, V, Groen, H J M, and De Ruysscher, D K M

Published
2020

19. Capmatinib (INC280) in patients (pts) with METex14-mutated advances NSCLC: an update from phase 2 GEOMETRY mono-1 study

Author

Wolf, J., Seto, T., Han, J. Y., Reguart, N., Garon, E. B., Groen, H. J., Tan, D. S. W., Hida, T., de Jonge, M., Orlov, S., V, Smit, E. F., Souquet, P., Vansteenkiste, J., Le Mouhaer, S., Robeva, A., Waldron-Lynch, M., Balbin, A., Fairchild, L., Giovannini, M., Heist, R. S., Wolf, J., Seto, T., Han, J. Y., Reguart, N., Garon, E. B., Groen, H. J., Tan, D. S. W., Hida, T., de Jonge, M., Orlov, S., V, Smit, E. F., Souquet, P., Vansteenkiste, J., Le Mouhaer, S., Robeva, A., Waldron-Lynch, M., Balbin, A., Fairchild, L., Giovannini, M., and Heist, R. S.

Published
2020

20. Capmatinib in patients with METex14-mutated advanced non-small cell lung cancer who received prior immunotherapy: The phase II GEOMETRY mono-1 study

Author

Vansteenkiste, J. F., Smit, E. F., Groen, H. J. M., Garon, E. B., Heist, R. S., Hida, T., Nishio, M., Kokowski, K., Grohe, C., Reguart, N., Mansfield, A. S., Robeva, A., Ghebremariam, S., Waldron-Lynch, M., Akimov, M., Nwana, N., Giovannini, M., Wolf, J., Vansteenkiste, J. F., Smit, E. F., Groen, H. J. M., Garon, E. B., Heist, R. S., Hida, T., Nishio, M., Kokowski, K., Grohe, C., Reguart, N., Mansfield, A. S., Robeva, A., Ghebremariam, S., Waldron-Lynch, M., Akimov, M., Nwana, N., Giovannini, M., and Wolf, J.

Published
2020

21. Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small- cell lung cancer (NSCLC): results from cohort 6 of the phase 2 GEOMETRY mono-1 study

Author

Wolf, J., Groen, H. J. M., Akerley, W., Souquet, P. -J., Laack, E., Han, J. -Y., Smit, E. F., Mansfield, A. S., Garon, E. B., Tan, D. S. W., Heist, R. S., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M., Orlov, S., Wolf, J., Groen, H. J. M., Akerley, W., Souquet, P. -J., Laack, E., Han, J. -Y., Smit, E. F., Mansfield, A. S., Garon, E. B., Tan, D. S. W., Heist, R. S., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M., and Orlov, S.

Published
2020

22. Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study

Author

Wolf, J., Overbeck, T., Han, J. -Y., Hochmair, M., De Marinis, F., Ohashi, K., Smit, E. F., Power, D., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M., Heist, R. S., Wolf, J., Overbeck, T., Han, J. -Y., Hochmair, M., De Marinis, F., Ohashi, K., Smit, E. F., Power, D., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M., and Heist, R. S.

Published
2020

23. Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study

Author

MS Radiotherapie, Cancer, Witlox, W J A, Ramaekers, B L T, Joore, M A, Dingemans, A-M C, Praag, J, Belderbos, J, Tissing-Tan, C, Herder, G, Haitjema, T, Ubbels, J F, Lagerwaard, J, El Sharouni, S Y, Stigt, J A, Smit, E F, van Tinteren, H, van der Noort, V, Groen, H J M, De Ruysscher, D K M, MS Radiotherapie, Cancer, Witlox, W J A, Ramaekers, B L T, Joore, M A, Dingemans, A-M C, Praag, J, Belderbos, J, Tissing-Tan, C, Herder, G, Haitjema, T, Ubbels, J F, Lagerwaard, J, El Sharouni, S Y, Stigt, J A, Smit, E F, van Tinteren, H, van der Noort, V, Groen, H J M, and De Ruysscher, D K M

Published
2020

50. Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

Author

Witlox, W. J. A., primary, Ramaekers, B. L. T., additional, Groen, H. J. M., additional, Dingemans, A. M., additional, Praag, J., additional, Belderbos, J., additional, van der Noort, V., additional, van Tinteren, H., additional, Joore, M. A., additional, and De Ruysscher, D. K. M., additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results